Replies to post #146091 on NanoViricides Inc. (NNVC)

[loanranger]

I guess this news explains your return from a 3 year hiatus to make a few points, some of which I agree with.
"Your start with relatively health people "
No, you start with HEALTHY people in the Phase 1a.

"Phase II will expand the demographics."
Not necessarily. If there is a Phase 2 it will recruit a much larger group of patients and they won't be healthy.

"Your questions will become OBE with all the positive outcomes."
OBE? Help me out here:
https://www.acronymfinder.com/OBE.html

My questions related to sample sizes, inclusion/exclusion criteria and fuzzy language. I thought they were decent questions and I know there's at least one person here who can either address them or tell me they're inconsequential. I think that would better be done BEFORE all the positive outcomes are revealed since the answers may have a bearing on how those outcomes are interpreted.

[4gh1rx]

NNVC - features

NNVC - 11/13/2023 catalysts

$NNVC

__________________
Quadruple bottom chart






_________________________________
$NNVC *** $NNVC *** $NNVC *** $NNVC *** $NNVC *** $NNVC *** NNVC

[4gh1rx]

NNVC - 11/13/2023 catalysts

$NNVC - Low Float

_____________________________

Low float - 11.7 milly.


******NanoViricides, Inc. is possibly the first laboratory in the world to have developed an orally effective nanomedicine.

_________________________________
$NNVC *** $NNVC *** $NNVC *** $NNVC *** $NNVC *** $NNVC *** NNVC